In this article (Cancer Epidemiol Biomarkers Prev 2012;21:800–9), which was published in the May 2012 issue of Cancer Epidemiology, Biomarkers & Prevention (1), the authors regret a typographical error that appeared in Table 1. The value for "Breast conservation surgery" appeared as 7.707. The correct value is 7,707. A corrected table is shown below.

Table 1.

Summary of major patient characteristics at baseline

CharacteristicsAll, N = 20,027 (%)
Age, mean (y) 72.2 
Age group  
 65–69 years 6,781 (33.9) 
 70–74 years 7,125 (33.6) 
 75–79 years 6,121 (30.6) 
AJCC stage  
 I 11,506 (57.5) 
 II 7,203 (36.0) 
 III 1,318 (6.6) 
ER/PR status  
 Positive* 13,798 (68.9) 
 Negative 2,502 (12.5) 
 Both ER and PR unknown 3,727 (18.6) 
Histologic grade  
 Poor 5,018 (25.1) 
 Moderate 6,894 (34.4) 
 Well 2,827 (14.1) 
 Unknown 5,288 (26.4) 
First recurrence  
 0–5 years 6,041 (30.2) 
 0–10 years 7,372 (36.8) 
Charlson Index score  
 0 17,179 (85.8) 
 1 1,099 (5.5) 
 2+ 636 (3.2) 
 Unknown 1,113 (5.5) 
Surgery  
 Breast conservation surgery 7,707 (38.5) 
 Mastectomy 10,551 (52.7) 
 Non 1,769 (8.8) 
Radiotherapy  
 Yes 7,396 (36.9) 
 No 12,631 (63.1) 
Chemotherapy  
 Yes 2,799 (14.0) 
 No 17,228 (86.0) 
CharacteristicsAll, N = 20,027 (%)
Age, mean (y) 72.2 
Age group  
 65–69 years 6,781 (33.9) 
 70–74 years 7,125 (33.6) 
 75–79 years 6,121 (30.6) 
AJCC stage  
 I 11,506 (57.5) 
 II 7,203 (36.0) 
 III 1,318 (6.6) 
ER/PR status  
 Positive* 13,798 (68.9) 
 Negative 2,502 (12.5) 
 Both ER and PR unknown 3,727 (18.6) 
Histologic grade  
 Poor 5,018 (25.1) 
 Moderate 6,894 (34.4) 
 Well 2,827 (14.1) 
 Unknown 5,288 (26.4) 
First recurrence  
 0–5 years 6,041 (30.2) 
 0–10 years 7,372 (36.8) 
Charlson Index score  
 0 17,179 (85.8) 
 1 1,099 (5.5) 
 2+ 636 (3.2) 
 Unknown 1,113 (5.5) 
Surgery  
 Breast conservation surgery 7,707 (38.5) 
 Mastectomy 10,551 (52.7) 
 Non 1,769 (8.8) 
Radiotherapy  
 Yes 7,396 (36.9) 
 No 12,631 (63.1) 
Chemotherapy  
 Yes 2,799 (14.0) 
 No 17,228 (86.0) 

NOTE: ER+/no PR data, ER+/PR+, ER+/PR−, or ER−/PR+, or no ER data/PR+

1.
Cheng
L
,
Swartz
MD
,
Zhao
H
,
Kapadia
AS
,
Lai
D
,
Rowan
PJ
, et al
Hazard of recurrence among women after primary breast cancer treatment—a 10-year follow-up using data from SEER-Medicare
.
Cancer Epidemiol Biomarkers Prev
2012
;
21
:
800
9
.